ICG farma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 39,870,492 | 40,292,578 | 49,738,710 | 50,872,096 | 52,194,772 | 54,812,656 | 72,901,378 | 82,091,463 |
| Profit before tax | 4,079,288 | 5,316,475 | 3,570,327 | 3,401,005 | 2,969,398 | 4,413,197 | 5,330,465 | 5,619,635 |
| Net profit | 3,468,687 | 4,361,430 | 3,070,640 | 2,905,492 | 2,541,786 | 3,748,790 | 4,578,741 | 4,754,512 |
| Equity | 12,730,138 | 7,310,928 | 5,381,568 | 6,137,612 | 6,645,553 | 7,852,557 | 8,682,508 | 8,858,279 |
| Liabilities | 1,127,937 | 3,598,127 | 3,692,268 | 2,533,819 | 3,990,601 | 2,230,554 | 6,414,258 | 10,448,835 |
| Non-current assets | 694,142 | 364,121 | 255,138 | 211,750 | 1,938,249 | 2,828,533 | 779,472 | 738,721 |
| Current assets | 13,463,142 | 10,552,089 | 8,975,549 | 8,696,629 | 8,999,272 | 7,192,770 | 14,397,300 | 18,292,444 |
| Total assets | 14,157,284 | 10,916,210 | 9,230,687 | 8,908,379 | 10,937,521 | 10,021,303 | 15,176,772 | 19,031,165 |
|
Taxes paid
|
||||||||
| Social insurance contributions | - | - | - | - | - | 226,417 | 331,389 | 394,841 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -8.6% | +1.1% | +23.4% | +2.3% | +2.6% | +5.0% | +33.0% | +12.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 24.5% | 40.0% | 33.3% | 32.6% | 23.2% | 37.4% | 30.2% | 25.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 27.2% | 59.7% | 57.1% | 47.3% | 38.2% | 47.7% | 52.7% | 53.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.7% | 10.8% | 6.2% | 5.7% | 4.9% | 6.8% | 6.3% | 5.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 10.2% | 13.2% | 7.2% | 6.7% | 5.7% | 8.1% | 7.3% | 6.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.5 | 0.7 | 0.4 | 0.6 | 0.3 | 0.7 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 1,269,086 | 1,354,372 | 1,626,336 | 1,754,210 | 1,759,372 | 1,822,029 | 2,133,697 | 2,189,106 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ICG farma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-03-18 | 2025-03-19 | 25.59 |
| 2022-02-17 | 2022-02-17 | 21.31 |
ICG farma - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-04 | 2025-04-04 | 19274.55 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ICG farma, UAB (code 302244351) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €82.09M, up 12.6% year on year and 49.8% over two years. Net profit reached €4.75M, compared with €4.58M in 2024 and €3.75M in 2023, while the profit margin narrowed from 6.8% in 2023 to 6.3% in 2024 and 5.8% in 2025. The balance sheet expanded further in 2025, with total assets of €19.03M, equity of €8.86M and liabilities of €10.45M. Short-term assets accounted for €18.29M of total assets, while long-term assets were €738.7K. Key indicators remained strong, including return on equity of 53.7%, return on assets of 25.0%, debt-to-equity of 1.18 and asset turnover of 4.31x. Revenue per employee was €2.22M and profit per employee €128.5K, indicating high operating productivity.